XORTX Therapeutics Inc. (XRTX)

NASDAQ: XRTX · IEX Real-Time Price · USD

1.762

-0.108 (-5.78%)

At close: Jul 2, 2024, 3:40 PM

1.810

+0.048 (2.72%)

After-hours: Jul 2, 2024, 7:55 PM EDT

XORTX Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	1.64	1.62	0.79	0.53	0.29
Research & Development	2.42	6.76	0.68	0.28	0.04
Other Operating Expenses	1.98	1.91	1.44	0.56	0.24
Operating Expenses	6.05	10.29	2.91	1.37	0.57
Operating Income	-6.05	-10.29	-2.91	-1.37	-0.57
Interest Expense / Income	-0.25	-0.1	0	0.01	0.04
Other Expense / Income	-3.63	-2.47	-1.34	-0.09	0.03
Pretax Income	-2.16	-7.72	-1.58	-1.28	-0.63
Net Income	-2.16	-7.72	-1.58	-1.28	-0.63
Shares Outstanding (Basic)	2	1	1	1	1
Shares Outstanding (Diluted)	2	1	1	1	1
Shares Change	33.91%	35.25%	47.77%	24.34%	-
EPS (Basic)	-1.09	-5.22	-1.44	-1.71	-1.08
EPS (Diluted)	-1.09	-5.22	-1.44	-1.71	-1.08
Free Cash Flow	-6.59	-8.98	-4.8	-0.73	-0.25
Free Cash Flow Per Share	-3.32	-6.07	-4.39	-0.98	-0.42
EBITDA	-2.27	-7.76	-1.56	-1.25	-0.57
Depreciation & Amortization	0.14	0.06	0.01	0.02	0.02
EBIT	-2.41	-7.82	-1.57	-1.27	-0.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).